Optiver Holding B.V. Shattuck Labs, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 66 shares of STTK stock, worth $126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66Holding current value
$126% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STTK
# of Institutions
61Shares Held
30.4MCall Options Held
36KPut Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$12.7 Million1.42% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$10.6 Million0.53% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$8.93 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.13MShares$4.07 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $80.9M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...